PEMETREXED DITROMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Pemetrexed Ditromethamine patents expire, and when can generic versions of Pemetrexed Ditromethamine launch?
Pemetrexed Ditromethamine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in PEMETREXED DITROMETHAMINE is pemetrexed ditromethamine. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pemetrexed ditromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pemetrexed Ditromethamine
A generic version of PEMETREXED DITROMETHAMINE was approved as pemetrexed ditromethamine by HOSPIRA on June 10th, 2022.
Summary for PEMETREXED DITROMETHAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | PEMETREXED DITROMETHAMINE at DailyMed |
Pharmacology for PEMETREXED DITROMETHAMINE
| Drug Class | Folate Analog Metabolic Inhibitor |
| Mechanism of Action | Folic Acid Metabolism Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PEMETREXED DITROMETHAMINE
US Patents and Regulatory Information for PEMETREXED DITROMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-003 | Jun 10, 2022 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-001 | Jun 10, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-002 | Jun 10, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
